Biogen partners with Johns Hopkins institute

Biogen Idec Inc., a Cambridge drug company, announced today a research collaboration with the newly formed Brain Science Institute at Johns Hopkins University.

The collaboration will focus on the discovery and development of therapies for neurodegenerative disorders such as multiple sclerosis, Alzheimer's Disease, and Parkinson's Disease, Biogen Idec said.
(By Chris Reidy, Globe staff)